WVXU: Meet the UC doctor trying to change minds skeptical of the COVID-19 vaccine
Louito Edje, MD, says the COVID-19 vaccine is based on years of science
Louito Edje, MD, associate dean of graduate medical education at the University of Cincinnati College of Medicine and UC Medical Center, spoke with WVXU about why she is on a public relations blitz – she was featured in segments on CNBC, TMZ, BET and MSNBC - to change minds about vaccinations for COVID-19. The pandemic is having a disproportionate impact on Black Americans and Edje, a Black female physician, is hoping her participation in the Moderna vaccine trial and her voice may sway some opinions about vaccine safety and efficacy.
After her second dose, Edje was pretty sure she didn’t get a placebo as part of the vaccine trial. "I had a lead arm and it lasted about 24 hours and not much longer than that," Edje told WVXU listeners. "I was able to continue working." She feels fine now and says the risk of being in a trial group was worth it to her because she's lost four family members to COVID-19.
Listen to the WVXU interview with Louito Edje, MD, online.
Louito Edje, MD, seated is shown in the UC College of Medicine Simulation Center. Photo by Colleen Kelley/University of Cincinnati.
Impact Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Struggling with daily HIV meds?
March 23, 2026
For many people living with HIV, staying healthy depends on something deceptively simple: taking a pill every day. But for those navigating unstable housing, stigma, mental health challenges or addiction, that daily routine can be hard to maintain. As Yahoo!Health recently reported, a new study suggests there may be a better option.
Extended-release buprenorphine viable, safe during pregnancy
March 23, 2026
MedPage Today highlighted research led by the University of Cincinnati's John Winhusen published in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue.
Why are we so unhappy?
March 23, 2026
Suzie White, assistant professor in the School of Education, at the University of Cincinnati, spoke with Newsweek about the results of the 2026 World Happiness Report that placed the United States 23rd among countries.